Hypertrophic cardiomyopathy. Cardiomyocyte ultrastructure, the specific or stereotypic signs

Close metadata

Recommended articles:

Histological and ultrastructural analysis of biopsy specimens of donor heart under conditions of extended period of pharmaco-cold ischaemia. Russian Journal of Archive of Pathology. 2024;(5):33-41

Clinical, laboratory and morphological comparisons in cellular alteration under conditions of hypoxia. Russian Journal of Archive of Pathology. 2024;(5):42-52

Surgical treatment of mid-ventricular hypertrophic obstructive cardiomyopathy with apical aneurysm. Russian Journal of Cardiology and Cardiovascular Surgery. 2024;(5):545-549

Left ventricular myocardial mass index as a predictor of spontaneous rhythm recovery after cardioplegia in patients with obstructive hypertrophic cardiomyopathy. Russian Journal of Anesthesiology and Reanimatology. 2024;(6):30-37

Redo surgical treatment of a patient with hypertrophic cardiomyopathy and recurrent left ventricular outflow tract obstruction. Pirogov Russian Journal of Surgery. 2025;(2):123-127

Long-term outcomes after ethanol septal ablation in the treatment of patients with hypertrophic cardiomyopathy. Russian Journal of Cardiology and Cardiovascular Surgery. 2025;(1):23-27

Analysis of differential gene expression in myocardial tissue from patients with hypertrophic cardiomyopathy. Molecular Genetics, Microbiology and Virology. 2025;(1):17-23

Clinical manifestation of apical hypertrophic cardiomyopathy by syncope in the elderly. Russian Journal of Cardiology and Cardiovascular Surgery. 2025;(2):237-243

Hypertrophic cardiomyopathy (HCM) is a congenital disease caused by mutations in a number of sarcomere proteins. According to the type of mutation, clinical observations record similar clinical manifestations, myocardial pathological changes, and the timing of manifestation of the disease in HCM patients. Objective — to study cardiomyocyte (CMC) ultrastructural changes in the interventricular septum (IVS) of patients with HCM and evaluate their specificity for this pathology. Subject and methods. IVS myocardial samples taken from 44 HCM patients aged 18—59 years at IVS myoectomy underwent an electron microscopic study. The diameter of CMCs and their nuclei was measured in semithin sections. Results. A morphometric examination of the IVS myocardium in HCM patients revealed moderate hypertrophy of CMCs and their nuclei, the diameters of which averaged 23.7±4.4 and 5.2±0.9 μm, respectively. The IVS CMCs were characterized by the ultrastructural signs of hypertrophy: the larger size and number of structures ensuring contractile and synthetic functions; the myocytes contained higher amounts of myofibrils, intermyofibrillar mitochondria, granular endoplasmic reticulum cisterns, and free ribosomes. On the contrary, some CMCs had fewer myofibrils in the perinuclear region, which is an adaptive change under hemodynamic overload conditions. In addition, a number of myocytes displayed signs of dystrophic changes: the appearance of lipofuscin granules, myelin figures, phagosomes, lipid droplets, and vacuoles, which can fill all free sarcoplasmic zones. Conclusion. Ultrastructural changes characteristic of hypertrophy were found in IVS CMCs in HCM patients. In addition, there was partial myofibrillar loss and dystrophic changes in a number of myocytes, which are stereotypic compensatory-adaptive changes under hemodynamic overload conditions. All the above-mentioned changes in the CMC ultrastructure are characteristic of myocardial hypertrophy, but not specific for hypertrophic cardiomyopathy.

Keywords:

hypertrophic cardiomyopathy

cardiomyocytes

ultrastructure

hypertrophy

myofibrillar loss

dystrophic changes

Authors:

Sukhacheva T.V.

FGBU "Nauchnyĭ tsentr serdechno-sosudistoĭ khirurgii im. A.N. Bakuleva" RAMN, Moskva

ORCID: 0000-0001-6127-8688

Serov R.A.

Nauchnyĭ tsentr serdechno-sosudistoĭ khirurgii im. A.N. Bakuleva RAMN, Moskva

ORCID: 0000-0002-7962-7273

Bokeriia L.A.

Nauchnyĭ tsentr serdechno-sosudistoĭ khirurgii im. A.N. Bakuleva RAMN, Moskva;
Institut bioorganicheskoĭ khimii im. M.M. Shemiakina i Iu.A. Ovchinnikova, Moskva

List of references:

Geisterfer-Lowrance AA, Kass S, Tanigawa G, Vosberg HP, McKenna W, Seidman CE, Seidman JG. A molecular basis for familial hypertrophic cardiomyopathy: a beta-cardiac myosin heavy chain gene missense mutation. Cell. 1990;62(5):999-1006. https://doi.org/10.3892/ijmm.2017.2986
Richard P, Charron P, Carrier L, Ledeuil C, Cheav T, Pichereau C, Benaiche A, Isnard R, Dubourg O, Burban M, Gueffet JP, Millaire A, Desnos M, Schwartz K, Hainque B, Komajda M. Hypertrophic cardiomyopathy: distribution of disease genes, spectrum of mutations, and implications for a molecular diagnosis strategy. Circulation. 2003;107(17):2227-2232. https://doi.org/10.1016/s1062-1458(03)00298-8
García-Castro M, Coto E, Reguero Jr, Berrazueta Jr, Alvarez V, Alonso B, Sainz R, Martín M, Morís C. Mutations in sarcomeric genes MYH7, MYBPC3, TNNT2, TNNI3, and TPM1 in patients with hypertrophic cardiomyopathy. Rev Esp Cardiol. 2009;62(1):48-56. https://doi.org/10.1016/s1885-5857(09)71513-0
Niimura H, Bachinski LL, Sangwatanaroj S, Watkins H, Chudley AE, McKenna W, Kristinsson A, Roberts R, Sole M, Maron BJ, Seidman JG, Seidman CE. Mutations in the gene for cardiac myosin-binding protein C and late-onset familial hypertrophic cardiomyopathy. N Engl J Med. 1998;338(18):1248-1257. https://doi.org/10.1056/nejm199804303381802
Thierfelder L, Watkins H, MacRae C, Lamas R, McKenna W, Vosberg HP, Seidman JG, Seidman CE.M, Vosberg HP. Alpha-tropomyosin and cardiac troponin T mutations cause familial hypertrophic cardiomyopathy: a disease of the sarcomere. Cell. 1994;77(5):701-12. https://doi.org/10.1016/0092-8674(94)90054-x
Varnava AM, Elliott PM, Baboonian C, Davison F, Davies MJ, McKenna WJ. Hypertrophic cardiomyopathy: histopathological features of sudden death in cardiac troponin T disease. Circulation. 2001;104(12):1380-1384.
Maron BJ, Ferrans VJ, Roberts WC. Ultrastructural features of degenerated cardiac muscle cells in patients with cardiac hypertrophy. Am J Pathol. 1975;79(3):387-434.
Nunoda S, Genda A, Sekiguchi M, Takeda R. Left ventricular endomyocardial biopsy findings in patients with essential hypertension and hypertrophic cardiomyopathy with special reference to the incidence of bizarre myocardial hypertrophy with disorganization and biopsy score. Heart Vessels. 1985;1(3):170-175. https://doi.org/10.1007/bf02066413
Fidzianska A, Bilinska ZT, Walczak E, Witkowski A, Chojnowska L. Autophagy in transition from hypertrophic cardiomyopathy to heart failure. J Electron Microsc (Tokyo). 2010;59(2):181-183. https://doi.org/10.1093/jmicro/dfp048
Ferrans VJ, Morrow AG, Roberts WC. Myocardial ultrastructure in idiopathic hypertrophic subaortic stenosis. A study of operatively excised left ventricular outflow tract muscle in 14 patients. Circulation. 1972;45(4):769-792.
Schaper J, Froede R, Hein St, Buck A, Hashizume H, Speiser B, Friedl A, Bleese N. Impairment of the myocardial ultrastructure and changes of the cytoskeleton in dilated cardiomyopathy. Circulation. 1991;83(2):504-514. https://doi.org/10.1161/01.cir.83.2.504
Kajihara H, Taguchi K, Hara H, Iijima S. Electron microscopic observation of human hypertrophied myocardium. Acta Pathol Jpn. 1973;23(2):335-347.
Elsässer A, Schlepper M, Klövekorn WP, Cai WJ, Zimmermann R, Müller KD, Strasser R, Kostin S, Gagel C, Münkel B, Schaper W, Schaper J. Hibernating myocardium. An incomplete adaptation to ischemia. Circulation. 1997;96(9):2920-2931. https://doi.org/10.1161/01.cir.96.9.2920
Perennec J, Herreman F, Ameur A, Degeorges M, Hatt PY. Ultrastructural and histological study of left ventricular myocardium in mitral stenosis. Correlations with angiocardiographic indices of left ventricular function (in 11 observations). Basic Res Cardiol. 1980;75(2):353-364. https://doi.org/10.1007/bf01907583
Engedal H, Jensen H, Saetersdal TS. Ultrastructure of abnormal membrane inclusions in nuclei of human myocardial cells. Br Heart J. 1977;39(2):145-151.
Fidziańska A, Bilińska ZT, Tesson F, Wagner T, Walski M, Grzybowski J, Ruzyłło W, Hausmanowa-Petrusewicz I. Obliteration of cardiomyocyte nuclear architecture in a patient with LMNA gene mutation. J Neurol Sci. 2008;271(1-2):91-96. https://doi.org/10.1016/j.jns.2008.03.017
Saetersdal TS, Myklebust R, Skagseth E, Engedal H. Ultrastructural studies on the growth of filaments and sarcomeres in mechanically overloaded human hearts. Virchows Arch B Cell Pathol. 1976;21(2):91-112.
Legato MJ, Mulieri LA, Alpert NR. The ultrastructure of myocardial hypertrophy: why does the compensated heart fail? Eur Heart J. 1984;5(Suppl.F):251-269.
Egorova IF, Peniaeva EV, Bokeriia LA. Structural features of cardiomyocytes in the atrialized right ventricle in patients with Ebstein anomaly. Arkhiv patologii. 2014;76(2):13-16. (In Russ.)
Oxford EM, Danko CG, Kornreich BG, Maass K, Hemsley SA, Raskolnikov D, Fox PR, Delmar M, Moïse NS. Ultrastructural changes in cardiac myocytes from Boxer dogs with arrhythmogenic right ventricular cardiomyopathy. J Vet Cardiol. 2011;13(2):101-113. https://doi.org/10.1016/j.jvc.2011.03.002
Dedkov EI, Stadnikov AA, Russell MW, Borisov AB. Formation of leptofibrils is associated with remodelling of muscle cells and myofibrillogenesis in the border zone of myocardial infarction. Micron. 2007;38(6):659-667. https://doi.org/10.1016/j.micron.2006.08.006
Pavlovich ER. Ul’trastruktura leptomernykh fibrill v provodyashchikh i rabochikh miotsitakh serdtsa mlekopitayushchikh raznykh vidov. Mezhdunarodnyi zhurnal prikladnykh i fundamental’nykh issledovanii. 2010;5:74-75. (In Russ.)
Maron BJ, Ferrans VJ. Significance of multiple intercalated discs in hypertrophied human myocardium. Am J Pathol. 1973;73(1):81-96.
Sepp R, Severs NJ, Gourdie RG. Altered patterns of cardiac intercellular junction distribution in hypertrophic cardiomyopathy. Heart. 1996;76(5):412-417. https://doi.org/10.1136/hrt.76.5.412
Elsässer A, Vogt AM, Nef H, Kostin S, Möllmann H, Skwara W, Bode C, Hamm C, Schaper J. Human hibernating myocardium is jeopardized by apoptotic and autophagic cell death. J Am Coll Cardiol. 2004;43(12):2191-2199. https://doi.org/10.1016/j.jacc.2004.02.053
Shimomura H, Terasaki F, Hayashi T, Kitaura Y, Isomura T, Suma H. Autophagic degeneration as a possible mechanism of myocardial cell death in dilated cardiomyopathy. Jpn Circ J. 2001;65(11):965-968. https://doi.org/10.1253/jcj.65.965
Saito T, Asai K, Sato S, Hayashi M, Adachi A, Sasaki Y, Takano H, Mizuno K, Shimizu W. Autophagic vacuoles in cardiomyocytes of dilated cardiomyopathy with initially decompensated heart failure predict improved prognosis. Autophagy. 2016;12(3):579-587. https://doi.org/10.1080/15548627.2016.1145326
Kassiotis C, Ballal K, Wellnitz K, Vela D, Gong M, Salazar R, Frazier OH, Taegtmeyer H. Markers of autophagy are downregulated in failing human heart after mechanical unloading. Circulation. 2009;120(Suppl.11):S191-S197. https://doi.org/10.1161/CIRCULATIONAHA.108.842252
Nakai A, Yamaguchi O, Takeda T, Higuchi Y, Hikoso S, Taniike M, Omiya S, Mizote I, Matsumura Y, Asahi M, Nishida K, Hori M, Mizushima N. The role of autophagy in cardiomyocytes in the basal state and in response to hemodynamic stress. Nat Med. 2007;13:619-624. https://doi.org/10.1038/nm1574
Saito T, Asai K, Sato S, Takano H, Mizuno K, Shimizu W. Ultrastructural features of cardiomyocytes in dilated cardiomyopathy with initially decompensated heart failure as a predictor of prognosis. Eur Heart J. 2015;36(12):724-733. https://doi.org/10.1093/eurheartj/ehu404 Received 12.03.19

Close metadata